arrow
M

Miriam J. Johnson

University of Hull
H指数:55
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparing the effectiveness, cost-effectiveness and implementation of low-dose oral modified release morphine in people with chronic breathlessness: a synopsis of a RCT and process evaluation

比较低剂量口服缓释吗啡在慢性呼吸困难患者中的疗效、成本效益及实施情况:一项随机对照试验和过程评估的概要

2026-05-010
PRE
Addressing barriers to interprofessional working with homecare workers in community palliative care: Insights from a multi-site qualitative case study

解决社区临终关怀中与居家护理工作者开展跨专业合作的障碍:一项多站点定性案例研究的见解

2025-11-240
OA
Implementing breathlessness self-management in low- and middle-income countries: co-design of breathlessness self-management resources for use in India

在低收入和中等收入国家实施呼吸困难自我管理:为在印度使用而共同设计呼吸困难自我管理资源

2025-11-240
OAAI
Morphine for chronic breathlessness (MABEL) in the UK: a health economic evaluation of a multisite, parallel-group, dose titration, double-blind, randomised, placebo-controlled trial

英国的吗啡治疗慢性呼吸困难 (MABEL): 对多站点,平行组,剂量滴定,双盲,随机,安慰剂对照试验的健康经济学评估

2025-11-050
OA
Morphine for chronic breathlessness (MABEL) in the UK: a multi-site, parallel-group, dose titration, double-blind, randomised, placebo-controlled trial

英国慢性呼吸困难 Morphine 治疗(MABEL)研究:一项多中心、平行组、剂量滴定、双盲、随机、安慰剂对照试验

2025-09-280
OAAI
I'm living in a 'no' world now…- A qualitative study of the widespread impact of living with chronic breathlessness, and experiences of identification and assessment of this symptom in an older, frail community-based population

我现在生活在一个 “不” 的世界 ......-对慢性呼吸困难生活的广泛影响的定性研究,以及在年老体弱的社区人群中识别和评估这种症状的经验

2025-01-240
OAAI
Mirtazapine to alleviate severe breathlessness in patients with COPD or ILD: an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trial (BETTER-B).
2024-10-300
PRE
Mirtazapineto alleviate severe breathlessness in patients with COPD or interstitial lung diseases (BETTER-B): an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trial

Mirtazapineto缓解COPD或间质性肺病患者的严重呼吸困难 (更好-B): 一项国际,多中心,双盲,随机,安慰剂对照,3期混合方法试验

2024-10-011
OAAI